Table 1.
Characteristics of patients involved in the study
| Parameter (mean ±SD) |
Groups | ||||
|---|---|---|---|---|---|
| Group I | Group II | Group III | Group IV | Group V | |
| Age (years) | 41.2 ±6 | 52.4 ±7 | 53.8 ±4 | 56.0 ±5 | 58.1 ±12 |
| AST (U/l) | 24.6 ±1.6 | 59.3 ±10*** | 59.7 ±16*** | 55.6 ±23*** | 112.9 ±36*** |
| ALT (U/l) | 25.4 ±2 | 64.1 ±9*** | 55.6 ±10*** | 36.95 ±16** | 113.3 ±30* |
| PT (s) | 12.8 ±0.5 | 13.7 ±0.7* | 14.7 ±1.4*** | 16.5 ±1.9*** | 14.3 ±1.5*** |
| Total protein (g %) | 6.2 ±0.5 | 5.8 ±0.3** | 4.2 ±0.5*** | 3.4 ±0.6*** | 3.1 ±0.16*** |
| Albumin (g %) | 4.1 ±0.4 | 3.7 ±0.4** | 3.6 ±0.6*** | 2.7 ±0.3*** | 2.9 ±0.6*** |
| Platelet count (103/µl) | 229.7 ±17 | 191.6 ±46*** | 123.4 ±38*** | 118.6 ±53*** | 186.6 ±20*** |
| Total bilirubin (mg %) | 0.4 ±0.1 | 0.72 ±0.4 | 1.2 ±0.7 | 3.8 ±0.5*** | 1.5 ±0.2 |
AST – aspartate aminotransferase, ALT – alanine aminotransferase, PT – prothrombin time, SD – standard deviation.
Statistically significant at: *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001 compared to the control group.